Market Executive Summary
Introspective Market Research Predicts that Immuno-oncology Drugs Market was valued USD xxxx unit in 2021 and is expected to reach USD xxxx Unit by the year 2028, growing at a CAGR of xx% globally.
Global Immuno-oncology Drugs Market Overview:
Global Immuno-oncology Drugs Market Report 2021 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2021-2028.This research study of Immuno-oncology Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Immuno-oncology Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Immuno-oncology Drugs market in 2021.
Global Immuno-oncology Drugs Market Segmentation
By Type, Immuno-oncology Drugs market has been segmented into:
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
By Application, Immuno-oncology Drugs market has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Immuno-oncology Drugs market are:
Amgen Inc
AstraZeneca
Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem Inc.
Lonza Group
Bio-Rad Laboratories Inc.
Avantor Inc.
Spring Bank Pharmaceuticals Inc.
Ferring Pharmaceuticals
Table of Contents
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Base Year
1.6 Scope of The Study
1.7 Market Segmentation
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Report Description
3.2 Market Overview: Market Definition and Scope
3.3 Porter's Five Forces Analysis
3.3.1 Bargaining Power of Supplier
3.3.2 Threat of New Entrants
3.3.3 Threat of Substitutes
3.3.4 Competitive Rivalry
3.3.5 Bargaining Power Among Buyers
3.4 Industry Value Chain Analysis
3.5 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
3.6 Pestle Analysis
3.7 Analysis of the Impact of Covid-19
Chapter 4: Immuno-oncology Drugs Market by Type
4.1 Immuno-oncology Drugs Market Overview By Type (2016-2027)
4.2 Immune Checkpoint Inhibitors
4.2.1 Market Overview
4.2.2 Key Market Trends, Growth Factors and Opportunities
4.2.3 Historic and Forecasted Market Size (2016-2027)
4.2.4 Historic and Forecasted Market Size By Region (2016-2027)
4.3 Immune System Modulators
4.3.1 Market Overview
4.3.2 Key Market Trends, Growth Factors and Opportunities
4.3.3 Historic and Forecasted Market Size (2016-2027)
4.3.4 Historic and Forecasted Market Size By Region (2016-2027)
4.4 Cancer Vaccines
4.4.1 Market Overview
4.4.2 Key Market Trends, Growth Factors and Opportunities
4.4.3 Historic and Forecasted Market Size (2016-2027)
4.4.4 Historic and Forecasted Market Size By Region (2016-2027)
4.5 Oncolytic Virus
4.5.1 Market Overview
4.5.2 Key Market Trends, Growth Factors and Opportunities
4.5.3 Historic and Forecasted Market Size (2016-2027)
4.5.4 Historic and Forecasted Market Size By Region (2016-2027)
4.6 Others
4.6.1 Market Overview
4.6.2 Key Market Trends, Growth Factors and Opportunities
4.6.3 Historic and Forecasted Market Size (2016-2027)
4.6.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 5: Immuno-oncology Drugs Market by Application
5.1 Immuno-oncology Drugs Market Overview By Application (2016-2027)
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Key Market Trends, Growth Factors and Opportunities
5.2.3 Historic and Forecasted Market Size (2016-2027)
5.2.4 Historic and Forecasted Market Size By Region (2016-2027)
5.3 Clinics
5.3.1 Market Overview
5.3.2 Key Market Trends, Growth Factors and Opportunities
5.3.3 Historic and Forecasted Market Size (2016-2027)
5.3.4 Historic and Forecasted Market Size By Region (2016-2027)
5.4 Ambulatory Surgical Centers
5.4.1 Market Overview
5.4.2 Key Market Trends, Growth Factors and Opportunities
5.4.3 Historic and Forecasted Market Size (2016-2027)
5.4.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competition Analysis
6.1.2 Strategies By Top Leading Players
6.1.3 Mergers and Acquisitions
6.1.4 Top Winning Strategies
6.2 AMGEN INC
6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Business Performance
6.2.4 Product Portfolio
6.2.5 Key Strategic Moves and Recent Developments
6.3 ASTRAZENECA
6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Business Performance
6.3.4 Product Portfolio
6.3.5 Key Strategic Moves and Recent Developments
6.4 PLC
6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Business Performance
6.4.4 Product Portfolio
6.4.5 Key Strategic Moves and Recent Developments
6.5 BRISTOL-MYERS SQUIBB
6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Business Performance
6.5.4 Product Portfolio
6.5.5 Key Strategic Moves and Recent Developments
6.6 CELGENE CORPORATION
6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Business Performance
6.6.4 Product Portfolio
6.6.5 Key Strategic Moves and Recent Developments
6.7 ELI LILLY AND COMPANY
6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Business Performance
6.7.4 Product Portfolio
6.7.5 Key Strategic Moves and Recent Developments
6.8 MERCK & CO.
6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Business Performance
6.8.4 Product Portfolio
6.8.5 Key Strategic Moves and Recent Developments
6.9 HOFFMANN-LA ROCHE AG
6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Business Performance
6.9.4 Product Portfolio
6.9.5 Key Strategic Moves and Recent Developments
6.10 JOHNSON & JOHNSON
6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Business Performance
6.10.4 Product Portfolio
6.10.5 Key Strategic Moves and Recent Developments
6.11 NOVARTIS INTERNATIONAL AG
6.11.1 Company Overview
6.11.2 Company Snapshot
6.11.3 Business Performance
6.11.4 Product Portfolio
6.11.5 Key Strategic Moves and Recent Developments
6.12 ABBVIE INC.
6.12.1 Company Overview
6.12.2 Company Snapshot
6.12.3 Business Performance
6.12.4 Product Portfolio
6.12.5 Key Strategic Moves and Recent Developments
6.13 PFIZER INC.
6.13.1 Company Overview
6.13.2 Company Snapshot
6.13.3 Business Performance
6.13.4 Product Portfolio
6.13.5 Key Strategic Moves and Recent Developments
6.14 SANOFI S.A.
6.14.1 Company Overview
6.14.2 Company Snapshot
6.14.3 Business Performance
6.14.4 Product Portfolio
6.14.5 Key Strategic Moves and Recent Developments
6.15 EMD SERONO INC.
6.15.1 Company Overview
6.15.2 Company Snapshot
6.15.3 Business Performance
6.15.4 Product Portfolio
6.15.5 Key Strategic Moves and Recent Developments
6.16 GILEAD SCIENCES INC.
6.16.1 Company Overview
6.16.2 Company Snapshot
6.16.3 Business Performance
6.16.4 Product Portfolio
6.16.5 Key Strategic Moves and Recent Developments
6.17 PROMETHEUS THERAPEUTICS & DIAGNOSTICS
6.17.1 Company Overview
6.17.2 Company Snapshot
6.17.3 Business Performance
6.17.4 Product Portfolio
6.17.5 Key Strategic Moves and Recent Developments
6.18 ADURO BIOTECH
6.18.1 Company Overview
6.18.2 Company Snapshot
6.18.3 Business Performance
6.18.4 Product Portfolio
6.18.5 Key Strategic Moves and Recent Developments
6.19 GALENA BIOPHARMA
6.19.1 Company Overview
6.19.2 Company Snapshot
6.19.3 Business Performance
6.19.4 Product Portfolio
6.19.5 Key Strategic Moves and Recent Developments
6.20 BAVARIAN NORDIC
6.20.1 Company Overview
6.20.2 Company Snapshot
6.20.3 Business Performance
6.20.4 Product Portfolio
6.20.5 Key Strategic Moves and Recent Developments
6.21 CELLDEX THERAPEUTICS
6.21.1 Company Overview
6.21.2 Company Snapshot
6.21.3 Business Performance
6.21.4 Product Portfolio
6.21.5 Key Strategic Moves and Recent Developments
6.22 IMMUNOCELLULAR THERAPEUTICS
6.22.1 Company Overview
6.22.2 Company Snapshot
6.22.3 Business Performance
6.22.4 Product Portfolio
6.22.5 Key Strategic Moves and Recent Developments
6.23 INCYTE
6.23.1 Company Overview
6.23.2 Company Snapshot
6.23.3 Business Performance
6.23.4 Product Portfolio
6.23.5 Key Strategic Moves and Recent Developments
6.24 DENDREON CORPORATION
6.24.1 Company Overview
6.24.2 Company Snapshot
6.24.3 Business Performance
6.24.4 Product Portfolio
6.24.5 Key Strategic Moves and Recent Developments
6.25 AGILENT TECHNOLOGIES INC.
6.25.1 Company Overview
6.25.2 Company Snapshot
6.25.3 Business Performance
6.25.4 Product Portfolio
6.25.5 Key Strategic Moves and Recent Developments
6.26 AGENUS INC.
6.26.1 Company Overview
6.26.2 Company Snapshot
6.26.3 Business Performance
6.26.4 Product Portfolio
6.26.5 Key Strategic Moves and Recent Developments
6.27 ENZO BIOCHEM INC.
6.27.1 Company Overview
6.27.2 Company Snapshot
6.27.3 Business Performance
6.27.4 Product Portfolio
6.27.5 Key Strategic Moves and Recent Developments
6.28 LONZA GROUP
6.28.1 Company Overview
6.28.2 Company Snapshot
6.28.3 Business Performance
6.28.4 Product Portfolio
6.28.5 Key Strategic Moves and Recent Developments
6.29 BIO-RAD LABORATORIES INC.
6.29.1 Company Overview
6.29.2 Company Snapshot
6.29.3 Business Performance
6.29.4 Product Portfolio
6.29.5 Key Strategic Moves and Recent Developments
6.30 AVANTOR INC.
6.30.1 Company Overview
6.30.2 Company Snapshot
6.30.3 Business Performance
6.30.4 Product Portfolio
6.30.5 Key Strategic Moves and Recent Developments
6.31 SPRING BANK PHARMACEUTICALS INC.
6.31.1 Company Overview
6.31.2 Company Snapshot
6.31.3 Business Performance
6.31.4 Product Portfolio
6.31.5 Key Strategic Moves and Recent Developments
6.32 FERRING PHARMACEUTICALS
6.32.1 Company Overview
6.32.2 Company Snapshot
6.32.3 Business Performance
6.32.4 Product Portfolio
6.32.5 Key Strategic Moves and Recent Developments
Chapter 7: Global Immuno-oncology Drugs Market By Region
7.1 Overview
7.2 North America
7.2.1 Market Overview
7.2.2 Key Market Trends, Growth Factors and Opportunities
7.2.2 Historic and Forecast Market Size by Type
7.2.3 Historic and Forecast Market Size by Application
7.2.4 Historic and Forecast Market Size by Country
7.3 Europe
7.3.1 Market Overview
7.3.2 Key Market Trends, Growth Factors and Opportunities
7.3.2 Historic and Forecast Market Size by Type
7.3.3 Historic and Forecast Market Size by Application
7.3.4 Historic and Forecast Market Size by Country
7.4 Asia Pacific
7.4.1 Market Overview
7.4.2 Key Market Trends, Growth Factors and Opportunities
7.4.2 Historic and Forecast Market Size by Type
7.4.3 Historic and Forecast Market Size by Application
7.4.4 Historic and Forecast Market Size by Country
7.5 Middle East & Africa
7.5.1 Market Overview
7.5.2 Key Market Trends, Growth Factors and Opportunities
7.5.2 Historic and Forecast Market Size by Type
7.5.3 Historic and Forecast Market Size by Application
7.5.4 Historic and Forecast Market Size by Country
7.6 South America
7.6.1 Market Overview
7.6.2 Key Market Trends, Growth Factors and Opportunities
7.6.2 Historic and Forecast Market Size by Type
7.6.3 Historic and Forecast Market Size by Application
7.6.4 Historic and Forecast Market Size by Country
List of Figures
List of Figures - Get a Sample Copy to Know More
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
